Other miRNAs, such as miR-216a, miR-17-5p, miR-26a or miR-30a, that specifically target Beclin-1, support the idea that induction of autophagy after cancer therapy triggers resistance (Zhu et al., 2009; Zhang et al., 2015; Li et al., 2016; Hou et al., 2017). The gene discussed is BECN1; the disease is cancer.